In-depth Analysis

    Micro - and nano - fragmented autologous adipose tissue is currently
    one of the most innovative tools in regenerative biological therapy.

    Mechanisms of Action

    • Anti-inflammatory effect: ↓ IL-1β, TNF-α; ↑ IL-10, TGF-β
    • Tissue regeneration through growth factors
    • Analgesic effect by reducing mechanical conflict
    • Immunomodulation against autoimmune processes

    Advanced Indications

    • Grade II–III osteoarthritis (Kellgren–Lawrence classification)
    • Meniscal lesions and post-meniscectomy
    • Ligament sprains and instability
    • Post-traumatic or post-surgical neuropathies
    • Chronic musculoskeletal pain

    MODERATE - TO - SEVERE OSTEOARTHRITIS

    Treatment Overview
    Autologous adipose tissue, processed through non-enzymatic micro- and nano-fragmentation, is a rich source of stromal vascular fraction (SVF), anti-inflammatory cytokines, growth factors, and extracellular matrix components. This biologic product exerts immunomodulatory, anti-inflammatory, and pro-regenerative effects.
    Biological and Physiopathological Effects
    → Reduction of chronic joint inflammation through down-regulation of pro-inflammatory cytokines (e.g., IL-1 β, TNF-α).
    → Improved joint lubrication via the release of hyaluronic acid and proteoglycans.
    → Stimulation of tissue regeneration through the paracrine action of mesenchymal-like cells (MSC-like).
    → Analgesic effect by reducing mechanical conflict and intra-articular edema.
    Specific Clinical Indications
    → Osteoarthritis (OA) of the knee, hip, ankle, and shoulder: grade II–III according to the Kellgren-Lawrence classification.
    → Athletes and sportspeople with early or subacute cartilage degeneration.
    → Patients who are not candidates for major surgery or are awaiting joint replacement.
    → Failure of previous corticosteroid or hyaluronic acid injections.
    Documented Clinical Benefits
    → Significant pain reduction (VAS) within the first 4–6 weeks post-injection.
    → Improved joint function (WOMAC, KOOS) with sustained effects for up to 12 months.
    → Enhanced quality of life (SF-36, EQ-5D) in active and athletic patients.
    → High safety profile: no serious adverse events reported in prospective and retrospective studies.
    Conclusions
    The use of micro- and nano-fragmented adipose tissue represents an innovative and biologically sustainable strategy for treating moderate-to-severe OA in sports medicine, offering tangible clinical benefits and delaying surgery in young and active patients.

    MENISCAL INJURIES

    Treatment Overview
    Autologous adipose tissue, processed through non-enzymatic micro- and nano-fragmentation, is a rich source of stromal vascular fraction (SVF), anti-inflammatory cytokines, growth factors, and extracellular matrix components. This biologic product exerts immunomodulatory, anti-inflammatory, and pro-regenerative effects, offering a promising regenerative approach for the conservative management of meniscal injuries, particularly in the context of sports medicine.
    Biological and Physiopathological Effects
    → Local anti-inflammatory action: modulation of cytokine expression (↓ IL-1 β, TNF-α; ↑ IL-10).
    → Enhanced meniscal healing: support for local cell proliferation and differentiation.
    → Pro-regenerative paracrine activity: release of trophic factors (e.g., VEGF, TGF-β, IGF-1).
    → Chondroprotective effect: slowing of post-injury joint degeneration.
    Specific Clinical Indications
    → Degenerative meniscal lesions in athletes or active individuals not suitable for meniscectomy.
    → Partial meniscal tears in subacute or chronic phases, particularly in avascular regions (white zone).
    → Post-meniscectomy patients with persistent joint pain and early degenerative changes.
    → Adjunctive therapy in meniscal repair procedures (e.g., arthroscopic suturing).
    → Prevention of menisco-chondral degeneration in young, high-demand patients.
    Documented Clinical Benefits
    → Progressive pain reduction (VAS) within 4–8 weeks post-injection.
    → Improved joint function (IKDC, Lysholm score) maintained for up to 12 months.
    → Earlier return to sport in non-surgical or subacute patients.
    → Excellent safety and tolerability profile: minimal risk due to autologous origin and mechanical processing.
    Conclusions
    Intra-articular injection of micro- or nano-fragmented adipose tissue is an innovative biological strategy for the treatment of meniscal injuries, especially in sports medicine. It offers a minimally invasive regenerative approach with symptomatic relief, joint protection, and potential reparative effects, while delaying or avoiding surgical interventions in young and active individuals.

    LIGAMENT INJURIES

    Treatment Overview
    Autologous adipose tissue, mechanically micro- or nano-fragmented, contains stromal vascular fraction (SVF), anti-inflammatory cytokines, growth factors, and extracellular matrix components that promote ligament healing through immune modulation, regeneration stimulation, and pain control.
    Biological and Physiopathological Effects
    → Reduction of local and systemic inflammation (↓ IL-6, TNF-α).
    → Stimulation of ligament fiber regeneration via paracrine signaling.
    → Increased vascularization and local cell recruitment.
    → Improved joint stability in conservative healing processes.
    Specific Clinical Indications
    → Partial anterior/posterior cruciate ligament (ACL/PCL) injuries suitable for non-surgical management.
    → Recurrent joint sprains (ankle, knee) with chronic ligament laxity.
    → Post-acute trauma management to support biological healing.
    → High-demand athletes with non-surgical ligament damage.
    Documented Clinical Benefits
    → Significant pain reduction (VAS) within 4–6 weeks.
    → Improved perceived joint stability and function (Tegner, IKDC scores).
    → Accelerated recovery and earlier return to sport.
    → Excellent safety profile with no serious adverse events reported.
    Conclusions
    Treatment with micro- or nano-fragmented adipose tissue offers an innovative biological solution for ligament injuries, combining anti-inflammatory, repair-promoting, and biomechanical benefits. It is ideal for sport-active individuals, providing a minimally invasive alternative to surgery in selected subacute or chronic cases.

    MUSCLE INJURIES

    Treatment Overview
    Autologous adipose tissue, processed via micro- or nano-fragmentation, is a biologically active source of stromal cells, anti-inflammatory cytokines, and growth factors (IGF-1, HGF, VEGF), which promote muscle regeneration. Ultrasound-guided injection enables precise delivery to the injury site.
    Biological and Physiopathological Effects
    → Activation of myofibrillar regeneration via paracrine signaling
    → Inflammatory modulation and inhibition of post-traumatic fibrosis
    → Enhanced revascularization and improved tissue oxygenation
    → Restoration of muscle architecture and contractile function
    Specific Clinical Indications
    → Grade II–III traumatic muscle injuries (strains, tears)
    → Delayed healing or frequent relapses in high-load muscle groups
    → Fibrotic remodeling with functional impairment
    → Biological adjunct in rehabilitation of professional athletes
    → Conservative option in patients unfit for surgery
    Documented Clinical Benefits
    → Shortened functional recovery time
    → Reduced recurrence and scar tissue formation
    → Improved muscle strength and tissue quality
    → Excellent safety, no immunologic response (autologous origin)
    Conclusions
    Micro- or nano-fragmented adipose tissue is a promising regenerative tool in the treatment of complex muscle injuries. It enhances biological healing, reduces fibrosis, and accelerates return to sport – especially relevant in sports medicine and performance rehabilitation.

    PERIPHERAL NEUROPATHIES

    Treatment Overview
    Autologous adipose tissue, processed via mechanical micro- or nano-fragmentation, provides a rich biological matrix of stromal vascular fraction (SVF), anti-inflammatory cytokines, neurotrophic factors, and extracellular matrix components. Perineural or intraneural injection in selected cases offers neuroprotective, anti-inflammatory, and regenerative effects in peripheral neuropathies, aiding functional nerve recovery.
    Biological and Physiopathological Effects
    → Neuroprotective action via NGF, BDNF, GDNF release.
    → Reduction of perineural inflammation and modulation of fibrotic response.
    → Stimulation of axonal regeneration and remyelination.
    → Local analgesic effect by reducing nociceptive sensitization.
    Specific Clinical Indications
    → Median nerve neuropathy (Carpal Tunnel Syndrome) – recurrent or refractory cases.
    → Post-traumatic neuropathies (stretch, crush, entrapment injuries).
    → Ulnar nerve entrapment at the elbow.
    → Chronic neuralgias (post-surgical or idiopathic).
    → Adjunct to surgical nerve decompression to reduce fibrosis and recurrence.
    Documented Clinical Benefits
    → Significant pain reduction (NRS/VAS) up to 60–80% within 8–12 weeks.
    → Improved sensory and motor recovery in affected dermatomes.
    → Faster functional recovery and reduced need for analgesic drugs.
    → Excellent safety profile, minimal inflammatory or immune-related risks.
    Conclusions
    The application of micro- and nano-fragmented adipose tissue offers a novel, minimally invasive therapeutic strategy for chronic and recurrent peripheral neuropathies. Its mechanisms – neuroprotection, nerve regeneration, and pain modulation – make it highly suitable in regenerative neuro-orthopedics and sports medicine.

    SYNOVITIS

    Treatment Overview
    Micro- or nano-fragmented autologous adipose tissue is used as an intra-articular injectable therapy to reduce chronic synovial inflammation and restore joint homeostasis. It is rich in stromal cells, anti-inflammatory factors (IL-10, TGF-β), and extracellular matrix components, capable of modulating synovial activity and improving synovial fluid quality.
    Biological and Physiopathological Effects
    → Inhibition of synovial inflammatory response (↓ IL-1 β, TNF-α)
    → Reduction of synovial proliferation and joint effusion
    → Protection of cartilage from pro-inflammatory mediators
    → Immunomodulatory rebalancing of the joint microenvironment
    Specific Clinical Indications
    → Reactive or persistent synovitis post-trauma or post-surgery
    → Chronic idiopathic synovitis or overload-induced inflammation
    → Inflammatory arthropathies with residual synovitic activity
    → Synovitic complications in athletes with high joint stress
    → Adjunctive biological support to conservative therapies
    Documented Clinical Benefits
    → Reduction in joint pain and swelling
    → Improved joint mobility and synovial fluid quality
    → Decreased need for repeated corticosteroid injections
    → Excellent tolerability with no significant adverse effects
    Conclusions
    Micro- or nano-fragmented adipose tissue injection is a promising anti-inflammatory and regenerative therapy for chronic or recurrent synovitis. It provides an innovative and safe option for joint preservation, particularly suitable for sports medicine and non-surgical joint management.

    CHRONIC PAIN

    Treatment Overview
    Micro- and nano-fragmented autologous adipose tissue is a rich source of mesenchymal stromal cells, anti-inflammatory cytokines, and bioactive molecules that can modulate the neuroinflammatory circuits involved in chronic pain. It is typically delivered via ultrasound-guided injection near the affected structures (joints, soft tissues, nerve sheaths).
    Biological Effects and Mechanisms of Action
    → Local immunomodulation (↓ IL-1 β, TNF-α, ↑ IL-10)
    → Reduction of peripheral and central sensitization
    → Trophic support to nerve endings and perineural tissues
    → Restoration of tissue homeostasis and reduction of oxidative stress
    → Promotion of repair mechanisms in chronically inflamed tissue
    Specific Clinical Indications
    → Chronic musculoskeletal pain (e.g. tendinopathies, enthesopathies)
    → Peripheral neuropathic pain, entrapment syndromes
    → Chronic joint pain not amenable to surgery (knee, shoulder, hip)
    → Complex Regional Pain Syndrome (CRPS Type I/II)
    → Athletes with persistent pain limiting performance
    Documented Clinical Benefits
    → Significant reduction in pain intensity (VAS/NRS)
    → Improved motor function and quality of life
    → Long-lasting effect (>6–12 months in some studies)
    → Non-pharmacologic, non-surgical treatment alternative
    → High safety profile with no systemic adverse reactions
    Conclusions
    Injection of micro- or nano-fragmented adipose tissue offers a regenerative, anti-inflammatory, and neuroprotective therapeutic option for chronic pain management, especially in patients unresponsive to conventional treatments or wishing to avoid long-term drug therapy or surgery.